Clinical Trial Update: Ranolazine a Potential New Therapeutic Application [Phase 4]

View source ↗

Summary

Phase 4 trial for ranolazine as a potential new indication was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Stunning

Drugs mentioned

• Ranolazine (ranolazine)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Myocardial Stunning | Phase 4 | Status: WITHDRAWN